BSE Live
Sep 29, 16:01Prev. Close
165.00
Open Price
166.50
Bid Price (Qty.)
164.55 (100)
Offer Price (Qty.)
168.00 (22)
NSE Live
Sep 30, 10:21Prev. Close
166.17
Open Price
164.60
Bid Price (Qty.)
167.00 (56)
Offer Price (Qty.)
168.38 (64)
Profit & Loss account of Nath Bio-Genes (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 360.42 | 331.15 | 300.04 | 277.15 | 305.67 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 360.42 | 331.15 | 300.04 | 277.15 | 305.67 | |
Total Operating Revenues | 362.31 | 332.62 | 301.29 | 278.36 | 307.56 | |
Other Income | 4.73 | 0.65 | 0.56 | 1.85 | 1.67 | |
Total Revenue | 367.04 | 333.28 | 301.85 | 280.22 | 309.23 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 12.51 | 11.02 | 5.31 | 3.56 | 8.96 | |
Operating And Direct Expenses | 177.71 | 99.95 | 70.49 | 93.53 | 122.86 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -96.66 | -19.92 | 11.98 | 4.99 | -21.76 | |
Employee Benefit Expenses | 30.31 | 27.98 | 23.23 | 24.78 | 23.69 | |
Finance Costs | 9.65 | 9.10 | 10.12 | 10.61 | 8.82 | |
Depreciation And Amortisation Expenses | 3.79 | 3.26 | 3.01 | 3.08 | 2.82 | |
Other Expenses | 186.14 | 163.20 | 141.39 | 114.27 | 107.10 | |
Total Expenses | 323.45 | 294.60 | 265.53 | 254.82 | 252.48 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 43.58 | 38.67 | 36.32 | 25.40 | 56.75 | |
Exceptional Items | 0.54 | 3.45 | 0.00 | -88.78 | 0.00 | |
Profit/Loss Before Tax | 44.12 | 42.12 | 36.32 | -63.39 | 56.75 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 2.04 | 1.92 | 1.19 | 2.34 | 0.19 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | 0.00 | 0.00 | 1.61 | 0.69 | |
Tax For Earlier Years | -0.05 | 0.03 | -0.03 | 0.00 | 0.21 | |
Total Tax Expenses | 1.98 | 1.95 | 1.15 | 3.95 | 1.09 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 42.14 | 40.18 | 35.17 | -67.34 | 55.66 | |
Profit/Loss From Continuing Operations | 42.14 | 40.18 | 35.17 | -67.34 | 55.66 | |
Profit/Loss For The Period | 42.14 | 40.18 | 35.17 | -67.34 | 55.66 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 21.72 | 19.81 | 18.51 | -36.00 | 29.29 | |
Diluted EPS (Rs.) | 21.72 | 19.81 | 18.51 | -36.00 | 29.29 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 3.80 | 3.80 | 3.80 | 3.80 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 |
14.07.2025
Nath Bio-Genes Standalone June 2025 Net Sales at Rs 280.17 crore, up 14.88% Y-o-Y
14.07.2025
Nath Bio-Genes Consolidated June 2025 Net Sales at Rs 283.70 crore, up 16.33% Y-o-Y
02.05.2025
Nath Bio-Genes Consolidated March 2025 Net Sales at Rs 51.97 crore, up 20.75% Y-o-Y
02.05.2025
Nath Bio-Genes Standalone March 2025 Net Sales at Rs 49.37 crore, up 14.71% Y-o-Y
14.07.2025
Nath Bio-Genes Standalone June 2025 Net Sales at Rs 280.17 crore, up 14.88% Y-o-Y
14.07.2025
Nath Bio-Genes Consolidated June 2025 Net Sales at Rs 283.70 crore, up 16.33% Y-o-Y
02.05.2025
Nath Bio-Genes Consolidated March 2025 Net Sales at Rs 51.97 crore, up 20.75% Y-o-Y
02.05.2025
Nath Bio-Genes Standalone March 2025 Net Sales at Rs 49.37 crore, up 14.71% Y-o-Y